United They Stand? Differing Device Platforms Share FDA Oversight Plank
This article was originally published in The Gray Sheet
Executive Summary
Device advocacy groups credit a maturing industry presence on Capitol Hill, reflected by CEO-level participation, with achieving relevant Medicare reforms and a focus on FDA accountability
You may also be interested in...
AdvaMed President Ubl Brings Detailed Policy Approach To Industry Agenda
The choice of Stephen Ubl as AdvaMed's president & CEO reflects board members' preference for detailed knowledge of the industry over mere political clout
AdvaMed President Ubl Brings Detailed Policy Approach To Industry Agenda
The choice of Stephen Ubl as AdvaMed's president & CEO reflects board members' preference for detailed knowledge of the industry over mere political clout
Global Challenges In 2003: Japanese Pricing, EU Reclassifications
European regulatory authorities are on the verge of upclassifying several surgically invasive device categories, despite fervent Eucomed-led opposition mounted during 2003